The sequence effect in de novo Parkinson's disease

Area of Science:

• Neurology
• Movement Disorders
• Parkinson's Disease Research

Background:

• The sequence effect (SE) is characterized by progressive slowness or decreased amplitude in repetitive movements.
• SE is a recognized feature of bradykinesia and is considered unique to Parkinson's disease (PD).
• Previously, SE was documented in advanced PD but not in drug-naïve patients.

Purpose of the Study:

• To determine if the sequence effect (SE) can be objectively measured in drug-naïve Parkinson's disease (PD) patients.
• To investigate the presence of SE in the early stages of PD before medication intervention.

Main Methods:

• Utilized a computer-based, modified Purdue pegboard for SE measurement.
• Assessed 4 drug-naïve PD patients, comparing findings to a previous study on advanced PD patients.

Main Results:

• Observed progressive slowness during repetitive movements, indicative of SE.
• A strong statistical trend for SE was noted with the right hand, though not statistically significant.
• No statistical significance for SE was found with either the more or less affected hands.

Conclusions:

• The sequence effect (SE) is identifiable in drug-naïve PD patients using objective measurements.
• Findings support SE as an early-stage feature of Parkinson's disease, present even without medication.
• This study validates SE as a measurable characteristic in both early and advanced stages of PD.